TAVI specific sex consideration

Abstract

The impact of sex on baseline characteristics and morphological and clinical presentation of degenerative aortic stenosis has been widely demonstrated but poorly understood. Moreover, differently from valve surgery, where patients were predominantly male, both sexes have been well represented in percutaneous treatment of aortic stenosis (AS), and women appeared to derive greater benefit with transfemoral aortic valve implantation (TAVI) compared to surgical treatment. This review focuses on sex-specific differences in epidemiology, pathophysiology, diagnostic issues, treatment options, and clinical outcomes of degenerative AS. Moreover, we evaluate how sex-based TAVI management, from device selection to procedural tricks, may affect outcomes.

Keywords

Transcatheter aortic valve implantation / aortic stenosis / sex-specific differences / device selection / clinical management

References

[1] Garcia M,Merz CN,Manson JE.Cardiovascular disease in women: clinical perspectives.Circ Res2016;118:1273-93 PMCID:PMC4834856

[2] Calabrò P,Gragnano F.Working Group of Interventional Cardiology of the Italian Society of CardiologyAre we ready for a gender-specific approach in interventional cardiology?.Int J Cardiol2019;286:226-33

[3] Iung B,Rosenhek R.EORP VHD II InvestigatorsContemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey.Circulation2019;140:1156-69

[4] Baumgartner H,Bax JJ.ESC Scientific Document Group2017 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J2017;38:2739-91

[5] Virani SS,Benjamin EJ.American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics-2020 update: a report from the American Heart Association.Circulation2020;141:e139-596

[6] Shames S.Sex differences in aortic valve calcification.Circ Cardiovasc Imaging2013;6:8-10

[7] Summerhill VI,Orekhov AN,Myasoedova VA.Sex-specific features of calcific aorticvalve disease.Int J Mol Sci2020;21:5620

[8] Chandrasekhar J,Mehran R.Valvular heart disease in women, differential remodeling, and response to new therapies.Curr Treat Options Cardiovasc Med2017;19:74

[9] Cramariuc D,Lønnebakken MT.Sex differences in cardiovascular outcome during progression of aortic valve stenosis.Heart2015;101:209-14 PMCID:PMC4316939

[10] Nguyen V,Melissopoulou M.Sex differences in the progression of aortic stenosis and prognostic implication: the COFRASA-GENERAC Study.JACC Cardiovasc Imaging2016;9:499-501

[11] McNeely C.Mitral valve surgery in women: another target for eradicating sex inequality.Circ Cardiovasc Qual Outcomes2016;9:S94-6

[12] Tribouilloy C,Rusinaru D.Excess mortality and undertreatment of women with severe aortic stenosis.J Am Heart Assoc2021;10:e018816 PMCID:PMC7955469

[13] Généreux P,O'Gara PT.Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis.J Am Coll Cardiol2016;67:2263-88

[14] Steeds RP,Thambyrajah J.IMPULSE registry groupIMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe.Open Heart2021;8:e001443 PMCID:PMC7798778

[15] Singh A,Greenwood JP.Symptom onset in aortic stenosis: relation to sex differences in left ventricular remodeling.JACC Cardiovasc Imaging2019;12:96-105

[16] Dobson LE,Uddin A.Gender influences left ventricular remodelling in the setting of aortic stenosis but does not appear to impact on reverse remodelling following transcatheter aortic valve implantation.J Cardiovasc Magn Reson2015;17:P332

[17] Bech-hanssen O,Houltz E,Larsson S.Gender differences in patients with severe aortic stenosis: impact on preoperative left ventricular geometry and function, as well as early postoperative morbidity and mortality.Eur J Cardiothorac Surg1999;15:24-30

[18] Chin CW,Luo E.Echocardiography underestimates stroke volume and aortic valve area: implications for patients with small-area low-gradient aortic stenosis.Can J Cardiol2014;30:1064-72 PMCID:PMC4161727

[19] Michelena HI,Miller FA.Inconsistent echocardiographic grading of aortic stenosis: is the left ventricular outflow tract important?.Heart2013;99:921-31

[20] Pibarot P.Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction.J Am Coll Cardiol2012;60:1845-53

[21] Tastet L,Pibarot P.Sex-related differences in the extent of myocardial fibrosis in patients with aortic valve stenosis.JACC Cardiovasc Imaging2020;13:699-711

[22] Boulif J,Slimani A.Assessment of aortic valve calcium load by multidetector computed tomography. Anatomical validation, impact of scanner settings and incremental diagnostic value.J Cardiovasc Comput Tomogr2017;11:360-6

[23] Nguyen V,Estellat C.Haemodynamic and anatomic progression of aortic stenosis.Heart2015;101:943-7

[24] Tuncay V,van Ooijen PM,Leiner T.Semiautomatic, quantitative measurement of aortic valve area using CTA: validation and comparison with transthoracic echocardiography.Biomed Res Int2015;2015:648283 PMCID:PMC4499628

[25] Kamperidis V,Katsanos S.Low gradient severe aortic stenosis with preserved ejection fraction: reclassification of severity by fusion of Doppler and computed tomographic data.Eur Heart J2015;36:2087-96

[26] Clavel MA,Messika-Zeitoun D.Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study.J Am Coll Cardiol2014;64:1202-13 PMCID:PMC4391203

[27] Nchimi A,Davin L,Oury C.Predicting disease progression and mortality in aortic stenosis: a systematic review of imaging biomarkers and meta-analysis.Front Cardiovasc Med2018;5:112 PMCID:PMC6113371

[28] Pradelli D,Mureddu G.Impact of aortic or mitral valve sclerosis and calcification on cardiovascular events and mortality: a meta-analysis.Int J Cardiol2013;170:e51-5

[29] Di Minno MND,Conte E.Cardiovascular morbidity and mortality in patients with aortic valve calcification: a systematic review and meta-analysis.J Cardiovasc Comput Tomogr2019;13:190-5

[30] Myasoedova VA,Songia P.Sex-specific differences in age-related aortic valve calcium load: a systematic review and meta-analysis.Ageing Res Rev2020;61:101077

[31] Cueff C,Cimadevilla C.Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction.Heart2011;97:721-6

[32] Clavel MA,Pibarot P.The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study.J Am Coll Cardiol2013;62:2329-38

[33] Voisine M,Shen M.Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve.J Am Heart Assoc2020;9:e015610 PMCID:PMC7660864

[34] Kvidal P,Hörte L.Observed and relative survival after aortic valve replacement.J Am Coll Cardiol2000;35:747-56

[35] Otto CM,Bonow RO.Writing Committee Members2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol2021;77:450-500

[36] Singh A,Treibel TA.Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement.Heart2019;105:1818-24 PMCID:PMC6900227

[37] Shan Y.Aortic stenosis in women.Heart2020;106:970-6

[38] Pighi M,Martucci G.Sex-specific determinants of outcomes after transcatheter aortic valve replacement.Circ Cardiovasc Qual Outcomes2019;12:e005363

[39] O'Connor SA,Gilard M.Revisiting sex equality with transcatheter aortic valve replacement outcomes: a collaborative, patient-level meta-analysis of 11,310 patients.J Am Coll Cardiol2015;66:221-8

[40] Kataruka A.Valve durability after transcatheter aortic valve implantation.J Thorac Dis2018;10:S3629-36 PMCID:PMC6242919

[41] Onorati F,Barbanti M.OBSERVANT Research GroupDifferent impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry.J Thorac Cardiovasc Surg2014;147:1529-39

[42] Chaker Z,Alqahtani F.Sex differences in the utilization and outcomes of surgical aortic valve replacement for severe aortic stenosis.J Am Heart Assoc2017;6:e006370 PMCID:PMC5634288

[43] Fuchs C,Rosenhek R.Gender differences in clinical presentation and surgical outcome of aortic stenosis.Heart2010;96:539-45

[44] Milavetz DL,Weston SA,Mullany CJ.Sex differences in left ventricular geometry in aortic stenosis: impact on outcome.Chest2000;117:1094-9

[45] Rahimtoola SH.Valvular heart disease/cardiac surgery.J Am Coll Cardiol2006;47:D37-40

[46] Tarantini G,Frank D.Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3.Catheter Cardiovasc Interv2021;97:876-84

[47] Chieffo A,Mehilli J.WIN-TAVI InvestigatorsAcute and 30-day outcomes in women after TAVR: results from the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) real-world registry.JACC Cardiovasc Interv2016;9:1589-600

[48] Chieffo A,Mehilli J.WIN-TAVI Investigators1-year clinical outcomes in women after transcatheter aortic valve replacement: results from the first WIN-TAVI registry.JACC Cardiovasc Interv2018;11:1-12

[49] Saad M,Pothineni NVK.Long-term outcomes with transcatheter aortic valve replacement in women compared with men: evidence from a meta-analysis.JACC Cardiovasc Interv2018;11:24-35

[50] Szerlip M,Holper E.Sex-specific outcomes of transcatheter aortic valve replacement with the SAPIEN 3 valve: insights from the PARTNER II S3 high-risk and intermediate-risk cohorts.JACC Cardiovasc Interv2018;11:13-20

[51] Wang TY,Callahan S.Gender disparities in management and outcomes following transcatheter aortic valve implantation with newer generation transcatheter valves.Am J Cardiol2019;123:1489-93

[52] Leon MB,Mack MJ.PARTNER 2 InvestigatorsTranscatheter or surgical aortic-valve replacement in intermediate-risk patients.N Engl J Med2016;374:1609-20

[53] Ruge H,Erlebach M.Access site related vascular complications with third generation transcatheter heart valve systems.Catheter Cardiovasc Interv2021;97:325-32

[54] Toggweiler S,Leipsic J.Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure.J Am Coll Cardiol2012;59:113-8

[55] Di Mario C,Ristalli F.A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral transcatheter aortic valve replacement.JACC Cardiovasc Interv2019;12:502-4

[56] Dencker D,Luk NH.Frequency and effect of access-related vascular injury and subsequent vascular intervention after transcatheter aortic valve replacement.Am J Cardiol2016;118:1244-50

[57] Witberg G,Adams H.Routine ultrasound or fluoroscopy use and risk of vascular/bleeding complications after transfemoral TAVR.JACC Cardiovasc Interv2020;13:1460-8

[58] Power D,Guedeney P.Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: a post hoc analysis from the BRAVO-3 randomized trial.Catheter Cardiovasc Interv2019;93:1374-81

[59] Buchanan GL,Montorfano M.A “modified crossover technique” for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.Catheter Cardiovasc Interv2013;81:579-83

[60] Claessen BE,Kini AS.Considerations for optimal device selection in transcatheter aortic valve replacement: a review.JAMA Cardiol2021;6:102-12

[61] Lee M,Piazza N.TAVI device selection: time for a patient-specific approach.EuroIntervention2016;12:Y37-41

[62] Fischer Q,Bouleti C.Performing optimal transcatheter aortic valve implantation: the need for tailored use of transcatheter valves.Arch Cardiovasc Dis2019;112:512-22

[63] Renker M.Choice of transcatheter heart valve: should we select the device according to each patient's characteristics or should it be “one valve fits all”?.Ann Transl Med2020;8:961 PMCID:PMC7475391

[64] Faquir N, Ren B, Van Mieghem NM, Bosmans J, de Jaegere PP. Patient-specific computer modelling - its role in the planning of transcatheter aortic valve implantation.Neth Heart J2017;25:100-5 PMCID:PMC5260618

[65] Abdelghani M,Allali A.Bioprosthetic valve performance after transcatheter aortic valve replacement with self-expanding versus balloon-expandable valves in large versus small aortic valve annuli: insights from the CHOICE trial and the CHOICE-extend registry.JACC Cardiovasc Interv2018;11:2507-18

[66] Hase H,Yanagisawa R.OCEAN-TAVI InvestigatorsTranscatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: the OCEAN-TAVI registry.Catheter Cardiovasc Interv2021;97:E875-86

[67] Lanz J,Walther T.Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.Lancet2019;394:1619-28

[68] Mauri V,Abumayyaleh M.Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched comparison.Circ Cardiovasc Interv2017;10:e005013

[69] Debry N,Amr G.Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.Catheter Cardiovasc Interv2016;87:797-804

[70] Ribeiro HB,Makkar RR.Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.J Am Coll Cardiol2013;62:1552-62

[71] Nai Fovino L,Massussi M.Incidence and feasibility of coronary access after transcatheter aortic valve replacement.Catheter Cardiovasc Interv2020;96:E535-41

[72] Nai Fovino L,Massussi M.Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR.J Am Heart Assoc2020;9:e016446 PMCID:PMC7670517

[73] Fontana GP,Groh M.Safety profile of an intra-annular self-expanding transcatheter aortic valve and next-generation low-profile delivery system.JACC Cardiovasc Interv2020;13:2467-78

[74] van Gils L,Latib A.TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery.EuroIntervention2016;12:Y22-7

[75] Reardon MJ,Popma JJ.SURTAVI InvestigatorsSurgical or transcatheter aortic-valve replacement in intermediate-risk patients.N Engl J Med2017;376:1321-31

[76] Mack MJ,Thourani VH.PARTNER 3 InvestigatorsTranscatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.N Engl J Med2019;380:1695-705

[77] Brouwer J,Delewi R.Aspirin with or without clopidogrel after transcatheter aortic-valve implantation.N Engl J Med2020;383:1447-57

[78] Nijenhuis VJ,Delewi R.Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation.N Engl J Med2020;382:1696-707

[79] Dangas GD,Wöhrle J.GALILEO InvestigatorsA controlled trial of rivaroxaban after transcatheter aortic-valve replacement.N Engl J Med2020;382:120-9

[80] Ten Berg J,Rocca B.Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.Eur Heart J2021;42:2265-9

[81] Katz M,Caixeta A.Brazilian TAVI Registry investigatorsGender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.Catheter Cardiovasc Interv2017;89:429-36

[82] Romano S,Mehran R,Capodanno D.Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease.Expert Opin Drug Saf2018;17:1041-52

[83] Nagao K,Morimoto T.CURRENT AS Registry InvestigatorsAnemia in patients with severe aortic stenosis.Sci Rep2019;9:1924 PMCID:PMC6374463

[84] Nicolas J,Cao D.Preprocedural anemia in females undergoing transcatheter aortic valve implantation: insights from the WIN-TAVI registry.Catheter Cardiovasc Interv2021;97:E704-15

[85] Bière L,Pinaud F.Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry.J Am Coll Cardiol2015;65:755-7

[86] Kodali S,Doshi D.Sex-specific differences at presentation and outcomes among patients undergoing transcatheter aortic valve replacement: a cohort study.Ann Intern Med2016;164:377-84

[87] Sannino A,Harrington K,Grayburn PA.Comparison of baseline characteristics and outcomes in men versus women with aortic stenosis undergoing transcatheter aortic valve implantation.Am J Cardiol2018;121:844-9

[88] Doshi R,Meraj P.Comparison of outcomes and complications of transcatheter aortic valve implantation in women versus men (from the national inpatient sample).Am J Cardiol2018;121:73-7

[89] Stehli J,Zaman S.Impact of gender on transcatheter aortic valve implantation outcomes.Am J Cardiol2020;133:98-104

[90] Chandrasekhar J,Yu J.STS/ACC TVT RegistrySex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014.J Am Coll Cardiol2016;68:2733-44

[91] Forrest JK,Popma JJ.Transcatheter aortic valve replacement in women versus men (from the US CoreValve Trials).Am J Cardiol2016;118:396-402

[92] D'Ascenzo F,Moretti C.Gender differences in patients undergoing TAVI: a multicentre study.EuroIntervention2013;9:367-72

[93] Buja P,Tamburino C.Italian Multicenter CoreValve Registry InvestigatorsComparison of variables in men versus women undergoing transcatheter aortic valve implantation for severe aortic stenosis (from Italian Multicenter CoreValve registry).Am J Cardiol2013;111:88-93

[94] Humphries KH,Rodés-Cabau J.Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis.J Am Coll Cardiol2012;60:882-6

[95] Czarnecki A,Koh M.Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.Catheter Cardiovasc Interv2017;90:486-94